Citation Impact
Citing Papers
Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis
2002
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
[3H]d-aspartate binding sites in the normal human spinal cord and changes in motor neuron disease: a quantitative autoradiographic study
1994
Expression of the glial glutamate transporter EAAT2 in the human CNS: an immunohistochemical study
1997
Aberrant expression of nitric oxide synthase III in Alzheimer’s disease: relevance to cerebral vasculopathy and neurodegeneration
2000
From Molecular Structure to Alzheimer Therapy.
1997
Oxidative Stress Hypothesis in Alzheimer's Disease
1997 Standout
Increased Basal Ganglia Iron Levels in Huntington Disease
1999
Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis
1998 StandoutNobel
Glutamate uptake
2001 Standout
Pathology of Parkinson’s disease
1991
The neural control of micturition
2008 Standout
Glutamate, excitotoxicity and amyotrophic lateral sclerosis
1997
Calcium‐permeable α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid receptors: A molecular determinant of selective vulnerability in amyotrophic lateral sclerosis
1997
Brain Lesions in Alcoholics
1993
Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate
1996 Standout
Novel Functions of Cholinesterases in Development, Physiology and Disease
1994
Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A−/−, 5-HT1B−/−, 5-HT2A−/−, 5-HT3A−/− and 5-HTT−/− knock-out male mice
2007 StandoutNobel
Widespread and abundant α‐synuclein pathology in a neurologically unimpaired subject
2005
Staging of brain pathology related to sporadic Parkinson’s disease
2002 Standout
Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective
2005 Standout
The neurobiology of zinc in health and disease
2005 Standout
Expression of five somatostatin receptor mRNAs in the human brain and pituitary
1996
Amyotrophic lateral sclerosis
2011 Standout
Dementia: The neurochemical basis of putative transmitter orientated therapy
1991
Parkinson's disease
2009 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
2005 StandoutNature
NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque‐competence, Aβ(1–40)ox and Aβ(1–42)ox
2001 StandoutNobel
High‐field magnetic resonance imaging of brain iron: birth of a biomarker?
2004
Pharmacological studies on novel muscarinic agonists, 1-oxa-8-azaspiro[4.5]decane derivatives, YM796 and YM954
1990
Nitric oxide (NO) and nociceptive processing in the spinal cord
1993 Standout
The immunology of stroke: from mechanisms to translation
2011 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Dementia with Lewy Bodies. A Distinct Non‐Alzheimer Dementia Syndrome?
1998
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
1996 Standout
Arisugacins, selective acetylcholinesterase inhibitors of microbial origin
1997 StandoutNobel
Revisiting the role of acetylcholinesterase in Alzheimer’s disease: cross-talk with P-tau and β-amyloid
2011
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
2003 Standout
Analysis of NMDA Receptors in the Human Spinal Cord
1997
Blood-Brain Barrier Breakdown in the Aging Human Hippocampus
2015 Standout
A Drosophila model of Parkinson's disease
2000 StandoutNature
The history of iron in the brain
1995
Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice
2005 Standout
ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions
1997 Standout
Neuronal Calcium Signaling
1998 Standout
The Lipid Peroxidation Product 4-Hydroxynonenal Impairs Glutamate and Glucose Transport and Choline Acetyltransferase Activity in NSC-19 Motor Neuron Cells
1999
Characterization of the Interaction of a Recombinant Soluble Neuroligin-1 with Neurexin-1β
2003 StandoutNobel
Oxygen free radicals and Parkinson's disease
1991
Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis
1992
Excitotoxicity and motor neurone disease: A review of the evidence
1994
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
1994 Standout
Intracellular amyloid-β in Alzheimer's disease
2007 Standout
Receptor localization in the mammalian dorsal horn and primary afferent neurons
1997
The role of iron neurotoxicity in ischemic stroke
2004
ALS-Linked Cu/Zn–SOD Mutation Increases Vulnerability of Motor Neurons to Excitotoxicity by a Mechanism Involving Increased Oxidative Stress and Perturbed Calcium Homeostasis
1999
Role of Aberrant Nitric Oxide Synthase‐3 Expression in Cerebrovascular Degeneration and Vascular‐mediated Injury in Alzheimer's Disease
2000
Amyotrophic Lateral Sclerosis
2001 Standout
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Immunocytochemical distribution of peptidergic and cholinergic fibers in the human amygdala: their depletion in Alzheimer's disease and morphologic alteration in non-demented elderly with numerous senile plaques
1993
TRPV1 and TRPA1 Mediate Peripheral Nitric Oxide-Induced Nociception in Mice
2009 StandoutNobel
The molecular pathology of Alzheimer's disease
1991 Standout
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
2000 StandoutNature
In Vivo Evaluation of Brain Iron in Alzheimer Disease Using Magnetic Resonance Imaging
2000
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Age-Associated mRNA and miRNA Expression Changes in the Blood-Brain Barrier
2019 StandoutNobel
The toxicity in vitro of β-amyloid protein
1995
Hippocampal atrophy in recurrent major depression.
1996 Standout
Increased Iron Levels and Decreased Tissue Integrity in Hippocampus of Alzheimer's Disease Detected in vivo with Magnetic Resonance Imaging
2013
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
The Free Radical Theory of Aging Matures
1998 Standout
α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies
1998 Standout
HFE Genotype, Particulate Air Pollution, and Heart Rate Variability
2006
RNA Synthesis in Pons Necessary for Maintenance of Bladder Overactivity After Cerebral Infarction in Rat.
2003
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Modulation of A beta adhesiveness and secretase site cleavage by zinc.
1994
Synaptic Control of Motoneuronal Excitability
2000
Spinal and Supraspinal Factors in Human Muscle Fatigue
2001 Standout
Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58.
1991 StandoutNobel
A Clinical Overview of Cholinesterase Inhibitors in Alzheimer’s Disease
2002
In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to alzheimer's disease β-protein
1986
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Neuronal DNA damage response‐associated dysregulation of signalling pathways and cholesterol metabolism at the earliest stages of A lzheimer‐type pathology
2015
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Emerging Targets in Photopharmacology
2016 StandoutNobel
Modulation of receptor-mediated inositol phospholipid breakdown in the brain
1991
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
1993 StandoutScience
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
1992 StandoutScience
From Molecular Structure to Alzheimer Therapy
1997
α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia
2004
The incidence of T2-weighted MR imaging signal abnormalities in the brain of cocaine-dependent patients is age-related and region-specific.
1999
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
2008 Standout
Oxidative stress in neurodegeneration: cause or consequence?
2004 Standout
Works of John M. Candy being referenced
Muscarinic Cholinergic Receptor Subtypes in Hippocampus in Human Cognitive Disorders
1988
Cortical somatostatinergic system not affected in Alzheimer's and Parkinson's diseases
1988
Neuropathological Diagnoses in Elderly Patients in Oslo: Alzheimers Disease, Lewy Body Disease, Vascular Lesions
1995
N-methyl-d-aspartate (NMDA) receptors in the spinal cord and motor cortex in motor neuron disease: a quantitative autoradiographic study using [3H]MK-801
1994
Brain iron homeostasis
1992
Neutron Activation Analysis of Trace Elements in Motor Neuron Disease Spinal Cord
1995
The quantitative autoradiographic distribution of [3H]MK-801 binding sites in the normal human spinal cord
1991
Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease
1985
Properties and possible significance of substance P and insulin fibrils
1981
Regional distribution of high-affinity [3H]somatostatin binding sites in the human brain
1986
Molecular Forms of Acetylcholinesterase and Butyrylcholinesterase in the Aged Human Central Nervous System
1986
Human cerebellar cortex possesses high affinity binding sites for [3H]somatostatin
1985
Stimulation by noradrenaline of inositol phospholipid breakdown in the rat hippocampus: effect of the ambient potassium concentration
1986
Modification of the muscarinic phosphatidylinositol response by K+ and N-methyl-d -aspartate
1986
Stability of adenylate cyclase coupling to somatostatin and corticotrophin-releasing-factor receptors in frozen post-mortem human cerebral cortex
1989
Molecular Forms of Butyrylcholinesterase in the Human Neocortex During Development and Degeneration of the Cortical Cholinergic System
1987
Raising the ambient potassium ion concentration enhances carbachol stimulated phosphoinositide hydrolysis in rat brain hippocampal and cerebral cortical miniprisms
1986
Amorphous aluminosilicates promote nucleation of amyloid β protein and tachykinins
1993
Stimulation of Inositol Phospholipid Breakdown in Rat Cortical and Hippocampal Miniprisms by Noradrenaline, 5‐Hydroxytryptamine and Carbachol: Some Methodological Aspects
1987
Neocortical Cholinergic Enzyme and Receptor Activities in the Human Fetal Brain
1986